000 02664nam  2200385zi 4500
0019.907038
003CaOODSP
00520240214102643
006m     o  d f      
007cr mn|||||||||
008220118e202203  onca    ob   f000 0 eng d
020 |a9780660416830
020 |z9780660416847 |q(incorrect)
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH144-98/2022E-PDF
24500|aLung cancer and ambient PM2.5 in Canada : |ba systematic review and meta-analysis.
264 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cMarch 2022.
264 4|c©2022
300 |a1 online resource (vii, 51 pages) : |billustrations (some colour)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aThe original publication file in PDF format was replaced with an accessible version on 14-02-2024 at the request of Health Canada.
500 |aIssued also in French under title: Cancer du poumon et PM2,5 ambiantes au Canada : revue systématique et méta-analyse.
500 |a"Pub.: 210602."
504 |aIncludes bibliographical references (pages 26-28).
5203 |a"In Canada, lung cancer is the most commonly diagnosed cancer, with a five-year survival rate under 20%. Fine particulate matter (PM2.5) is an important environmental risk factor for lung cancer. Additionally, the International Agency of Research for Cancer (IARC) determined that ambient particulate matter (PM) is a Group 1 carcinogen (2016), Health Canada (2013) concluded that chronic exposure to PM likely causes lung cancer mortality, and the US EPA (2019) concluded that the relationship between long-term exposure to PM2.5 and cancer was likely to be causal. Systematic review and meta-analysis methodology was implemented to provide quantitative evidence that long-term exposure to PM2.5 is associated with an increased risk of lung cancer specific to Canada. Additional qualitative evidence was provided to characterize other additional factors (such as confounders, effect modifiers, and the shape of the concentration-response curve) that may further contextualize the relationship of interest"--Abstract, page vii.
650 0|aLungs|xCancer|xRisk factors|zCanada.
650 0|aLungs|xCancer|xMortality|zCanada.
650 0|aParticulate matter|xHealth aspects|zCanada.
650 0|aCarcinogens|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tCancer du poumon et PM2,5 ambiantes au Canada : |w(CaOODSP)9.907041
85640|qPDF|s2.33 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H144-98-2022-eng.pdf